ROCL.U Stock Overview
Does not have significant operations. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Roth Ch Acquisition V Co. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$11.29 |
| 52 Week High | US$13.92 |
| 52 Week Low | US$10.60 |
| Beta | -0.040 |
| 11 Month Change | -5.13% |
| 3 Month Change | 0.62% |
| 1 Year Change | 6.21% |
| 33 Year Change | 12.67% |
| 5 Year Change | n/a |
| Change since IPO | 12.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| ROCL.U | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | -1.7% | 2.5% | 1.6% |
| 1Y | 6.2% | 55.7% | 32.3% |
Return vs Industry: ROCL.U underperformed the US Capital Markets industry which returned 55.8% over the past year.
Return vs Market: ROCL.U underperformed the US Market which returned 32.4% over the past year.
Price Volatility
| ROCL.U volatility | |
|---|---|
| ROCL.U Average Weekly Movement | n/a |
| Capital Markets Industry Average Movement | 3.8% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ROCL.U's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine ROCL.U's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | n/a | Byron Roth | rocl.rothch.com |
Roth Ch Acquisition V Co. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. It intends to acquire businesses in the business services, consumer, healthcare, technology, wellness, and sustainability sectors.
Roth Ch Acquisition V Co. Fundamentals Summary
| ROCL.U fundamental statistics | |
|---|---|
| Market cap | US$55.54m |
| Earnings (TTM) | -US$4.35m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-12.8x
P/E RatioIs ROCL.U overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ROCL.U income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$4.35m |
| Earnings | -US$4.35m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.88 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -30.4% |
How did ROCL.U perform over the long term?
See historical performance and comparison